Searched for
EMCURE PHARMACEUTICALS EXECUTIVE
Delhivery elevates six executives to C-suite roles amid expansion pushLogistics firm Delhivery has promoted six senior executives to C-suite positions. These appointments support the company's expansion across...- Stocks in news: Paytm, Bajaj Auto, L&T, Bharti Airtel, Hero MotoCorpMarkets closed lower amid global headwinds and geopolitical worries. Several companies like Paytm, Bajaj Auto, and L&T are in focus due to ...
- ‘Doing what I do best’: Namita Thapar shares new reel amid controversyEmcure Pharmaceuticals' Namita Thapar shared a health awareness video amid controversy over her namaz remarks. Meanwhile, Lenskart faced ba...
- Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...
- Emcure cuts semaglutide injection price by average 47%The starting dose price is cut by 55% to Rs 3,999 per month (four weekly doses). The innovator semaglutide is available in a once-weekly pe...
- Emcure Pharmaceuticals Q4 Results: Profit surges 63% YoY on strong domestic and international growthEmcure Pharmaceuticals reported a 63% YoY rise in Q4 net profit to Rs 197 crore, driven by strong domestic and international growth. EBITDA...
- From Mumbai slums to cruising in a Lamborghini in Dubai. He is just 29. His story stuns Hotmail co-founder Sabeer BhatiaSabeer Bhatia, Hotmail's co-founder, sparked a debate about India's economic disparities after encountering a self-made millionaire from Dh...
- Rs 600 crore Shark Tank judge was mocked for weight and called ‘girl with moustache’ in school, opens up about being bulliedNamita Thapar, Executive Director of Emcure Pharmaceuticals and Shark Tank India judge, revealed her childhood bullying experiences, includ...
- Shark tank fame Namita Thapar shares an emotional Mirza Ghalib shayari post Emcure IPO's robust listingThe robust listing met expectations, reflecting the company's long-term potential. Analysts recommend that investors maintain their positio...
- Emcure Pharma shares debut with 31% premium over issue priceBefore listing, the company's shares traded at a Rs 360 premium in the grey market. It raised Rs 582 crore from anchor investors, including...
- IPO Analysis: Emcure has better-listed pharma alternativesEmcure Pharma, with its strong presence in gynaecology and HIV therapeutic areas, secured significant investments from anchor investors lik...
- IPO Calendar: Primary market gears up for another robust week as 3 companies look to raise Rs 2,700 crApart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, wh...
- Emcure Pharma to launch IPO in 3 months: Namita Thapar of Shark Tank fameShark Tank fame and Executive Director of Emcure Pharmaceuticals, Namita Thapar said at the ET NOW Global Business Summit 2024 on February ...
- Namita Thapar organises 'Top Gun: Maverick' screening for 200 Emcure employees, shares leadership lessons from the movieThe desi Shark held the special screen for her staff to drive away Monday blues.
- PEs in talks for Emcure stake; promoters eye $2 billion valuationJM Financial is advising the company for the stake sale.
- Pharma stocks soar despite US lawsuitAmong other listed stocks out of the five, Cadila Healthcare gained 2.87 per cent at Rs 512 at around the same time.
- US states sue 5 Indian generic drug makers over price cartelisationThe new lawsuit has also named some individual executives, including Rajiv Malik, president of Mylan, and Satish Mehta, MD of Emcure Pharma.
- Roche, Emcure may end pact to make 2 blockbuster drugsEmcure is still the distributor for those two drugs in India. Roche had handed out the manufacturing and marketing of trastuzumab and ritux...
- Bomaby High Court denies promoters of Mumbai-based Taj Pharmaceuticals Limited anticipatory bailTaj Pharma maintained in its defence that it was not selling the injections under the Bicnu brand and contended that its marketed injection...
- Apax, KKR in talks to acquire Blackstone stake in EmcureHealthcare is 1 of the 5 sectors in which Apax Partners invests globally, besides technology & telecom, retail & consumer, media, financial...
Load More
